The Los Angeles Dodgers have built a reputation for doing whatever it takes to win a World Series, and that relentless pursuit isn't slowing down anytime soon. But a recent injury to one of baseball's rising stars could give them an unexpected—and frankly, scary—advantage over the rest of the league.

Tarik Skubal, the dominant left-handed ace for the Detroit Tigers, recently underwent surgery, and his future is now clouded with uncertainty. Before this setback, Skubal was on track to land a massive contract, with teams lining up for his elite pitching. Now, according to ESPN's Kiley McDaniel, the injury has reopened questions about his durability, which could significantly impact his market value.

"The assumption is that Skubal will return this season looking close to the same pitcher he has been recently," McDaniel wrote. But he added that "durability questions after this surgery" could lead to a lower price in free agency. Sources suggest that instead of a long-term blockbuster deal, Skubal might now be more inclined to accept a shorter-term contract with opt-outs—exactly the kind of flexible, high-upside arrangement that Dodgers president Andrew Friedman loves to pursue.

For a team already stacked with talent and unafraid to spend, this is music to their ears. The Dodgers have shown time and again that they can turn injury "risks" into championship pieces. Adding a pitcher of Skubal's caliber on a short-term, team-friendly deal would be a nightmare for the rest of Major League Baseball—and a dream come true for Dodgers fans.

Of course, there's still the looming threat of a league-wide lockout, which could complicate contract negotiations and force teams to rethink their rosters. But if the Dodgers can navigate that storm and land Skubal on their terms, they'll once again prove why they're the team to beat.